Proto Labs受益于注塑业务强劲增长

Proto Labs benefits from strong growth in its injection molding business

Thanks to the rapid growth of its injection molding business, improved profit margins, and an upward adjustment of its full-year performance guidance, Proto Labs has reported record-high revenues for the second quarter of 2026.

Proto Labs注塑业务营收同比上涨13.1%，该公司季度营收创下1.493亿美元的历史新高。

Leading digital manufacturing service provider Proto Labs announced its second-quarter financial report, achieving record revenue. The growth in performance is primarily driven by the booming business of polymer material injection molding, while the company's overall manufacturing footprint continues to expand.

As of June 30, 2026, the company achieved revenue of $149.3 million for the quarter, representing a year-over-year increase of 10.6% compared to the same period in 2025. The injection molding business revenue grew by 13.1% year-over-year, while the CNC machining business revenue increased by 13.6%, reflecting strong market demand for the company's core manufacturing operations.

"This quarter, we once again delivered impressive results, achieving record revenue with double-digit growth, and both gross margin and operating profit margin have improved simultaneously," said Suresh Krishna, President and CEO of the company. "More importantly, there are increasing signs that our corporate strategy is taking effect, and large strategic clients are expanding their business cooperation with Proto Labs."

高分子业务驱动业绩走高

The injection molding segment achieved double-digit growth, reflecting the growing preference among many product development companies and manufacturers for Proto Labs’ rapid manufacturing capabilities to shorten the time to market for polymer components. The company’s digitally driven business model helps customers quickly transition from prototyping to mass production through injection molding.

Suresh Krishna noted that the injection molding business was a standout segment in the second quarter, with year-over-year growth of 13%, driven by market demand from the data center and aerospace and defense sectors.

“This substantial acceleration in business growth is highly significant, as it confirms the effectiveness of the work we have done in improving product quality, deepening customer engagement, and securing large orders,” he said. “Injection molding remains one of Proto Labs’ core differentiating competitive advantages, and the accelerated growth of this business also strongly demonstrates that our overall expansion strategy is effective.”

单客户对应总营收同比上涨16.7%，说明现有客户合作深度增加，同时公司在战略客户群体中成功拓展更多业务。该数据表明，客户正委托Proto Labs处理更多品类的制造需求，涵盖高分子零部件与金属零部件。

The improvement in profit margin reflects the enhancement of operational efficiency.

Proto Labs' profit margin improved significantly this quarter, with a GAAP gross margin of 46.4%, up from 44.3% in the second quarter of 2025. The non-GAAP gross margin increased by 200 basis points to 46.8%, compared to 44.8% in the same period last year.

The improvement in operating profit margin is particularly notable, with the GAAP operating profit margin rising from 3.7% in the same period last year to 7.6%. The non-GAAP operating profit margin reached 12.0%, an increase of 340 basis points compared to 8.6% in the second quarter of 2025.

"Revenue in the second quarter reached a record high, and profit margins significantly improved, fully demonstrating the strong power and scalability of our business model," said Chief Financial Officer Dan Schumacher. "While investing resources in strategic growth projects, we continue to maintain strong cash flow. We will continue to balance profit growth with rigorous execution to create value for our customers and shareholders."

Suresh Krishna also mentioned that the CNC machining business performed outstandingly, with the factory business growing by 20% year-on-year. The growth was driven by sustained strong demand in the aerospace and defense sectors, involving areas such as drones, satellites, and robotics.

"This quarter's performance also confirms a major important trend emerging in the company's overall business," he added. "Larger strategic customers are expanding and deepening their business cooperation with Proto Labs."

Strong cash flow supports investment in business expansion.

In this quarter, the company's cash flow from operating activities was $15.4 million. As of June 30, 2026, the balance of cash and investments was $162.9 million. The adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) reached $25.1 million, accounting for 16.8% of revenue; in the second quarter of 2025, this figure was $19.7 million, representing 14.6% of revenue.

GAAP diluted net income per share was $0.37, compared with $0.18 in the second quarter of 2025. Non-GAAP diluted net income per share was $0.60, compared with $0.41 in the same period last year.

Raised earnings guidance highlights growth momentum

Based on first‑half operating performance and the continued improvement across all business lines, Proto Labs has raised its full‑year 2026 revenue growth guidance to the 8%–10% range. The company expects third‑quarter 2026 revenue to be between $145 million and $153 million.

The company forecasts third-quarter GAAP diluted net earnings per share in the range of $0.34 to $0.42, and non-GAAP diluted net earnings per share in the range of $0.56 to $0.64.

“2026年上半年，我们已经证明Proto Labs既能交出优异财务成绩，又能同步推进面向未来的业务转型。”Suresh Krishna称，“客户、各项业务、各区域市场展现出的发展势头，令我们备受鼓舞。”

The outstanding performance of the injection molding business allows Proto Labs to fully capitalize on the market growth opportunities of rapid polymer manufacturing solutions. Companies across various industries aim to accelerate product development cycles and shorten time-to-market for new products, which will bring growth opportunities for the company.